The anti-obesity drugs market was valued at $1,605.36 million in 2022 and is estimated to reach $4,439.34 million by 2032, exhibiting a CAGR of 10.7% from 2023 to 2032.
Report Code : A03823 | Pages : 447 | Category : Life Sciences
The global opioids market was valued at $4.4 billion in 2020, and is projected to reach $6.1 billion by 2030, growing at a CAGR of 3.2% from 2021 to 2030.
Report Code : A03216 | Pages : 213 | Category : Life Sciences
The global COPD and asthma devices market is expected to reach $51,628.58 million by 2027, registering a CAGR of 4.30% during 2020-2027.
Report Code : A00469 | Pages : 276 | Category : Life Sciences
The global capnography market size accounted for $393.93 million in 2019, and is expected to reach $1,181.55 million by 2027, registering a CAGR of 13.5% from 2020 to 2027.
Report Code : A03600 | Pages : 271 | Category : Life Sciences
The global compression therapy market was valued at $3.2 billion in 2021, and is projected to reach $5.4 billion by 2031, growing at a CAGR of 5.4% from 2022 to 2031.
Report Code : A03966 | Pages : 400 | Category : Life Sciences
The global global sepsis diagnostic market was valued at $569.49 million in 2020, and is projected to reach $1.2 billion by 2030, growing at a CAGR of 7.8% from 2021 to 2030.
Report Code : A03908 | Pages : 205 | Category : Life Sciences
The global smart inhalers market size was valued at $34 million in 2018 and is estimated to reach $1,406 million by 2026, growing at a CAGR of 58.4% ...
Report Code : A01388 | Pages : 173 | Category : Life Sciences
The global invisible orthodontics market was valued at $4.6 billion in 2021, and is projected to reach $34.7 billion by 2031, growing at a CAGR of 22.6% from 2022 to 2031.
Report Code : A03365 | Pages : 370 | Category : Life Sciences
The global cystic fibrosis therapeutics market size was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026.
Report Code : A05134 | Pages : 187 | Category : Life Sciences
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
